Effects of combination therapy with cilostazol and probucol versus monotherapy with cilostazol on coronary plaque, lipid and biomarkers: SECURE study, a double-blind randomized controlled clinical trial. (Q44762337)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 April 2014
edit
Language Label Description Also known as
English
Effects of combination therapy with cilostazol and probucol versus monotherapy with cilostazol on coronary plaque, lipid and biomarkers: SECURE study, a double-blind randomized controlled clinical trial.
scientific article published on 4 April 2014

    Statements

    title
    Effects of combination therapy with cilostazol and probucol versus monotherapy with cilostazol on coronary plaque, lipid and biomarkers: SECURE study, a double-blind randomized controlled clinical trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    24705623
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24705623%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    13 March 2020
    main subject
    biomarker
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q44762337&oldid=1257367825"